FGF-23 was originally identified through a gene mutation in patients with autosomal dominant hypophosphatemic rickets or X-linked hypophosphatemic rickets that results in elevated serum levels of FGF-23 (White et al., 2000). Here, FGF23 is linked to autosomal dominant hypophosphatemic rickets.